D. R. Krishna

1.8k total citations
77 papers, 1.4k citations indexed

About

D. R. Krishna is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, D. R. Krishna has authored 77 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Pharmacology and 11 papers in Pharmacology. Recurrent topics in D. R. Krishna's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Drug-Induced Hepatotoxicity and Protection (7 papers). D. R. Krishna is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Drug-Induced Hepatotoxicity and Protection (7 papers). D. R. Krishna collaborates with scholars based in India, Germany and United States. D. R. Krishna's co-authors include Ulrich Klotz, A. Rama Narsimha Reddy, Vurimindi Himabindu, V. Himabindu, Bernhard Sperker, Péter Fritz, M.S. Shekar, Christine Fischer, Sripal Reddy Mada and Gautam Palit and has published in prestigious journals such as Gut, Biochemical Pharmacology and Journal of Ethnopharmacology.

In The Last Decade

D. R. Krishna

76 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. R. Krishna India 20 325 277 225 213 161 77 1.4k
Hanaa H. Ahmed Egypt 28 158 0.5× 613 2.2× 101 0.4× 176 0.8× 275 1.7× 198 2.5k
Zeng Fan-dian China 18 138 0.4× 379 1.4× 233 1.0× 65 0.3× 255 1.6× 65 1.4k
Tzuu‐Huei Ueng Taiwan 21 355 1.1× 330 1.2× 103 0.5× 123 0.6× 107 0.7× 77 1.3k
Zhen Yang China 29 377 1.2× 1.2k 4.2× 143 0.6× 341 1.6× 217 1.3× 118 2.6k
Md. Wasim Khan India 20 157 0.5× 397 1.4× 64 0.3× 92 0.4× 82 0.5× 61 1.2k
Reham Z. Hamza Saudi Arabia 24 162 0.5× 217 0.8× 119 0.5× 158 0.7× 90 0.6× 98 1.5k
Monica Valentovic United States 23 435 1.3× 392 1.4× 45 0.2× 135 0.6× 132 0.8× 116 1.9k
R.K. Kale India 22 261 0.8× 421 1.5× 151 0.7× 76 0.4× 92 0.6× 72 1.9k
Birija Sankar Patro India 22 172 0.5× 793 2.9× 209 0.9× 152 0.7× 119 0.7× 73 2.0k
Akram Jamshidzadeh Iran 31 485 1.5× 392 1.4× 67 0.3× 227 1.1× 147 0.9× 119 2.4k

Countries citing papers authored by D. R. Krishna

Since Specialization
Citations

This map shows the geographic impact of D. R. Krishna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. R. Krishna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. R. Krishna more than expected).

Fields of papers citing papers by D. R. Krishna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. R. Krishna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. R. Krishna. The network helps show where D. R. Krishna may publish in the future.

Co-authorship network of co-authors of D. R. Krishna

This figure shows the co-authorship network connecting the top 25 collaborators of D. R. Krishna. A scholar is included among the top collaborators of D. R. Krishna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. R. Krishna. D. R. Krishna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reddy, A. Rama Narsimha, et al.. (2010). In vitro cytotoxicity of multi-wall carbon nanotubes on human cell lines. Toxicological & Environmental Chemistry Reviews. 92(9). 1697–1703. 9 indexed citations
2.
Krishna, D. R., et al.. (2010). Anti-HIV, anti-tubercular and mutagenic activities of borrelidin. Indian Journal of Biotechnology. 9(3). 265–270. 8 indexed citations
3.
Reddy, A. Rama Narsimha, et al.. (2010). Multi wall carbon nanotubes induce oxidative stress and cytotoxicity in human embryonic kidney (HEK293) cells. Toxicology. 272(1-3). 11–16. 127 indexed citations
4.
Reddy, A. Rama Narsimha, et al.. (2010). Pulmonary toxicity assessment of multiwalled carbon nanotubes in rats following intratracheal instillation. Environmental Toxicology. 27(4). 211–219. 44 indexed citations
5.
Reddy, A. Rama Narsimha, et al.. (2010). Translocation and extra pulmonary toxicities of multi wall carbon nanotubes in rats. Toxicology Mechanisms and Methods. 20(5). 267–272. 37 indexed citations
6.
Vidyavathi, M., et al.. (2009). Rapid HPLC Determination of Venlafaxine in Microbial Biotransformation Studies. Current Trends in Biotechnology and Pharmacy. 3(1). 64–70. 2 indexed citations
7.
Srinivas, M., et al.. (2008). Protein Binding Studies of Gossypin by Equilibrium Dialysis. Current Trends in Biotechnology and Pharmacy. 2(2). 396–401. 3 indexed citations
8.
Srinivas, Maya, et al.. (2008). Influence of Diosmin Pretreatment on the Pharmacokinetics of Chlorzoxazone in Healthy Male Volunteers. Drug metabolism and drug interactions. 23(3-4). 311–322. 12 indexed citations
9.
Krishna, D. R., et al.. (2008). Influence of Some Bioflavonoids on Transport of Nitrendipine. Drug metabolism and drug interactions. 23(3-4). 299–310. 9 indexed citations
10.
Krishna, D. R., et al.. (2007). Histaminergic H1 receptors mediate L-histidine-induced anxiety in elevated plus-maze test in mice. Behavioural Pharmacology. 18(3). 213–217. 25 indexed citations
11.
An, Rui, et al.. (2005). Validated HPLC method for the determination of ornidazole in human serum and urine. Indian Journal of Pharmaceutical Sciences. 67(3). 302–306. 10 indexed citations
12.
Chandrasekhar, S., V. Jagadeshwar, Ch. Narsihmulu, et al.. (2004). Design, synthesis and cytotoxic studies on the simplified oxy analog of eleutherobin. Bioorganic & Medicinal Chemistry Letters. 14(14). 3687–3689. 9 indexed citations
13.
Krishna, D. R., et al.. (2003). Inflammation And Novel Therapeutic Approaches For Its Management. Indian Journal of Pharmaceutical Sciences. 65(6). 565–575.
14.
Chaluvadi, Madhusudana R., et al.. (2001). Bioflavonoids-Their Pharmacokinetics And Interaction With Cytochrorme P450 Isozymes And P-Glycoprotein. Indian Journal of Pharmaceutical Sciences. 63(3). 187. 1 indexed citations
15.
Krishna, D. R., et al.. (2000). Transdermal Aspirin : Influence Of Platelet Aggregation And Serum Lipid Peroxides. Indian Journal of Pharmaceutical Sciences. 62(3). 200. 2 indexed citations
16.
Krishna, D. R., et al.. (1995). In Vitro Protein Binding and Tissue Distribution of D(+) Usnic Acid. Drug metabolism and drug interactions. 12(1). 53–64. 12 indexed citations
17.
Krishna, D. R. & Ulrich Klotz. (1994). Extrahepatic Metabolism of Drugs in Humans. Clinical Pharmacokinetics. 26(2). 144–160. 324 indexed citations
18.
Krishna, D. R., et al.. (1991). Effect of (+)-usnic acid on testicular nucleic acids and epididymal spermatozoa in mice. Fitoterapia. 62(3). 258–260. 6 indexed citations
19.
Al‐Bekairi, Abdullah M., et al.. (1991). Mitodepressive, clastogenic and biochemical effects of (+)-usnic acid in mice. Journal of Ethnopharmacology. 33(3). 217–220. 34 indexed citations
20.
Walker, S., D. R. Krishna, Ulrich Klotz, & J. Christian Bode. (1989). Frequent non-response to histamine H2-receptor antagonists in cirrhotics.. Gut. 30(8). 1105–1109. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026